Cargando…
Evaluation of a Novel Nicotine Inhaler Device: Part 1—Arterial and Venous Pharmacokinetics
INTRODUCTION: In the United Kingdom, licensed nicotine-containing products can be recommended to reduce the harm associated with smoking. Many smokers find currently available nicotine replacement products unsatisfactory. The arterial and venous pharmacokinetics (PK) of nicotine delivered via a nove...
Autores principales: | Moyses, Chris, Hearn, Alex, Redfern, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282122/ https://www.ncbi.nlm.nih.gov/pubmed/25385878 http://dx.doi.org/10.1093/ntr/ntu228 |
Ejemplares similares
-
Evaluation of a Novel Nicotine Inhaler Device: Part 2—Effect on Craving and Smoking Urges
por: Moyses, Chris, et al.
Publicado: (2015) -
Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System
por: Teichert, Axel, et al.
Publicado: (2018) -
Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users
por: Liu, Jianmin, et al.
Publicado: (2022) -
Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette
por: Goldenson, Nicholas I., et al.
Publicado: (2022) -
Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability
por: Stiles, Mitchell F., et al.
Publicado: (2017)